- Major Women’s Health Study Supports Hormone Replacement Therapy in Early Menopause
- Organic Walnuts Tied to Serious E. Coli Illnesses
- More Than Half of Cats on Farm Where Bird Flu Infected Cows Died After Drinking Milk
- Biden Administration Could Reclassify Marijuana as Less Risky Drug
- Americans of Pacific Island Ethnicity Have Up to Triple the Rate of Cancer Deaths
- How Anger Could Raise Your Heart Risks
- EPA Clamps Down on Deadly Toxin Found in Paint Strippers
- Popular Teens (Especially Girls) May Get Less Sleep
- Years Prior to Menopause Are Danger Zone for Depression
- School Entry Rules Boost Kids’ HPV Vaccination Rates
New Test Estimates Risk of Heart Disease
A new screening test designed to estimate a person’s risk of developing coronary heart disease (CHD) has been approved by the U.S. Food and Drug Administration.
Results of a manufacturer study reviewed by the FDA indicate the test is better at discerning this risk in women, notably black women, the agency said in a news release.
The PLAC Test for Lp-PLA2 Activity, intended for people without a prior history of heart disease, measures a blood biomarker for arterial inflammation, a strong indicator of plaque buildup within arteries that supply blood to the heart.
Heart disease is the leading cause of death in the United States among ethnic groups including blacks, Hispanics and whites. The most common form of heart disease, CHD, leads to the deaths of some 385,000 people each year. About two-thirds of women and half of men who die suddenly of CHD have no prior symptoms, the FDA said.
The new test is produced by diaDexus Inc., based in South San Francisco.
More information
Visit the FDA to learn more.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.